SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Top Cited Papers
Open Access
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 184 (9), 2362-2371.e9
- https://doi.org/10.1016/j.cell.2021.02.042
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
This publication has 43 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Structural basis of receptor recognition by SARS-CoV-2Nature, 2020
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2Emerging Microbes & Infections, 2020
- Pseudotype Neutralization Assays: From Laboratory Bench to Data AnalysisMethods and Protocols, 2018
- Current status on the development of pseudoviruses for enveloped virusesReviews in Medical Virology, 2017
- HemI: A Toolkit for Illustrating HeatmapsPLOS ONE, 2014
- Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication FidelityPLoS Pathogens, 2013
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccinesJournal of Virological Methods, 2010